Presenters Info
- Hai Hu, Senior Director of Biomedical Informatics, Windber Research Institute
- Michael N. Liebman, Ph.D., Executive Director, Windber Research Institute & President and Managing Director, Strategic Medicine, Inc
- Mick Correll, Director Clinical Solutions, InforSense
Host,
Dave Menninger, VP Marketing & Product Management, InforSense
Date
19 September 2007
Time
11:00 ET (New York)
Duration
1 hour including Q&A
Description:
Unlock Insight from Your Clinical Data
From academic medical research centers to hospitals and health insurers, the healthcare industry continues to improve its capabilities for electronic data capture. Despite these advances, a gap remains in the ability of these IT systems to deliver knowledge and insight back to the very researchers and clinicians they are built to support. Please join Dr. Hai Hu from the Windber Research Institute to learn about some of the tools and techniques he and his colleagues are using to bridge this gap and deliver insight to their clinical community. In this webcast you will learn how to:
- Move beyond primary data capture systems to an analytical environment
- Explore patient populations: trend identification, hypothesis generation, and cohort analysis
- Make the most of longitudinal patient records and investigate temporal relationships of life and medical events
- Integrate patient and sample information to enhance tissue repositories
Who should attend:
- Clinical and biomedical researchers
- Data analysts and informaticians
- Medical and scientific officers
- Healthcare IT managers
Click here for more information on additional webcasts including "Streamlining Analysis and Annotation for Whole Genome Association Studies".
About Windber Research Institute
The Windber Research Institute is a translational medicine research center that focuses on bringing the problems in the clinic back to the research laboratory for analysis at the genomic, proteomic, image and informatic levels. It is focused in its research areas on women’s health, including obstetrics and gynecologic diseases including breast, ovarian, endometrial and cervical cancers, cardiovascular disease, obesity and diabetes, and processes of normal aging including menopause. It has worked closely with its partners at InforSense to develop an integrated research environment that is being extended to support physician decision making in collaboration with the patient. Major efforts in tissue banking, patient data acquisition and genomic research (sequencing, genotyping, gene expression, whole genome analysis) and proteomics (protein separation and identification) comprise the experimental focus. The biomedical informatics efforts include data modelling and warehousing, data mining and research into the development of disease models for risk assessment, prevention and early detection, including environmental and lifestyle factors.
Windber Research Institute collaborates closely with the Walter Reed Army Medical Center and with the Joyce Murtha Breast Care Center, the University of Pittsburgh Medical Center and Cancer Institute, Georgetown University, and the University of California-San Francisco in the areas of women’s health, cardiovascular disease and obesity. It is a private, non-profit research institute that is located approximately 1.5 hours from Pittsburgh, Pennsylvania, in the Laurel Highlands Mountains.
Additional information can be obtained at www.wriwindber.org.
About Strategic Medicine, Inc
Strategic Medicine, Inc (SMI) is an emerging healthcare company focused on translational medicine that will capitalize on the broad trend in healthcare information technology to integrate patient medical information to facilitate better clinical decisions, assess and improve quality of care, share information among hospital communities to improve outcomes, and provide rich clinical information to pharmaceutical companies for drug development and clinical candidate selection. SMI defines translational medicine as working with clinicians to identify real diagnostic and therapeutic problems, moving them into the research environment, and providing solutions through data analysis that are immediately applicable to improving the quality of care in the clinic. By merging clinical, molecular and imaging data, in a patient-centric data model that is longitudinally focused, while accessing a unique tissue repository, SMI is developing one of the first systems that can lead to viable translational and preventive medicine as a true clinical opportunity.
SMI is uniquely positioned in this evolving market. In association with the Windber Research Institute and its partners, the Company has developed a flexible and scaleable Internet-based data system that enables hospitals and hospital networks to realize near term data security, productivity and quality of care improvements, while paving the way for clinical trial participation, and the long term benefits of a truly interoperable, patient centric, personalized health record.
Additional information can be obtained at www.strategicmedicine.com
